Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chinese health sector calls for action on HAIs

This article was originally published in Clinica

Executive Summary

China’s nosocomial -hospital acquired - infections burden is affecting 10% of its patients yearly at a cost of more than RNB10bn (US$1.5bn) and needs to be addressed. This was the message conveyed by doctors and politicians at a meeting in October at the General Hospital of the People’s Liberation Army in Wuhan, China. Equipment such as respirators and blood dialysis machines, as well as hand cleanliness, were highlighted as key causes of hospital acquired infections (HAIs), which allegedly caused the death of eight newborn babies in Xi’an (the capital of northwest Shaanxi province) in September. Health ministry official Deng Min made the point that most HAIs are preventable and that greater attention therefore must be paid to pathogen isolation, asceptic surgery, and monitoring of hospital sanitation and ventilation, reports the Xinhua news agency. HAIs and a lack of proper HAI incidence data are a worldwide cause for concern. Current estimates are that around 6 million HAIs occur across the US, Europe and Japan annually. The US is estimated to have 1.7 million infections and 99,000 deaths from HAIs per year; and 3,000,000 patients across Europe are estimated to suffer from HAIs annually, with around 50,000 deaths occurring as a consequence of the infection.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT042157

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel